Citadel Advisors’s Electromed ELMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,100
Closed -$74K 13155
2025
Q1
$74K Buy
3,100
+300
+11% +$8.76K ﹤0.01% 11851
2024
Q4
$82.7K Sell
2,800
-900
-24% -$23.5K ﹤0.01% 11748
2024
Q3
$79.4K Sell
3,700
-600
-14% -$9.77K ﹤0.01% 11421
2024
Q2
$64.6K Buy
4,300
+2,200
+105% +$34.4K ﹤0.01% 11474
2024
Q1
$33.9K Buy
+2,100
New +$27.6K ﹤0.01% 12571
2023
Q1
Sell
-1,000
Closed -$10.5K 14888
2022
Q4
$10.5K Buy
+1,000
New +$10.2K ﹤0.01% 13617

Other funds holding ELMD

Citadel Advisors's ELMD Position: Q1 2026 in Review

Citadel Advisors increased its Electromed (ELMD) stake by 134% in Q1 2026, buying an estimated $290K and bringing the position to 19,461 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #9528.

Citadel Advisors first reported a position in ELMD in Q3 2013 and has held it in 20 quarters since. The position peaked at $765K in Q3 2025. 102 funds tracked by Wall St. Rank hold ELMD as of Q1 2026.

  • Citadel Advisors held 19,461 shares of Electromed worth $456K as of Q1 2026.
  • Citadel Advisors bought 11,131 Electromed shares in Q1 2026, an estimated $290K.
  • Electromed made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9528 holding.
  • Citadel Advisors first reported a position in Electromed in Q3 2013 and has held it in 20 quarters since.
  • Citadel Advisors's Electromed position peaked at $765K in Q3 2025.
  • 102 funds tracked by Wall St. Rank held Electromed as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.